With a potential COVID-19 vaccine moving closer to reality and the U.S government signing contracts for millions of potential doses, an unresolved question is who should be at the front of the line to get those first doses.

DUBLIN – Sanofi SA and Regeneron Pharmaceuticals Inc. are terminating all further development in COVID-19 of their interleukin-6 receptor inhibitor, Kevzara, following the antibody’s failure to meet the primary endpoint, as well as a key survival endpoint.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: The American Medical Association, Obelisk Ventures, Philips, Quest Diagnostics.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ctl Amedica, Medtronic, Roche, T2 Biosystems, Transmed7.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Amr, Apostherapy, Biocartis Group, Biolife Sciences, Biomerics Atl, Cardiologs, Clarity Diagnostics, Combinati, Esri, Fds, Fio, GI Supply, Healthplanone, Humana, Inspire Medical Systems, Ion Beam Applications, Laborie Medical Technologies, Leica Microsystems, Lifearc, Magentine Medgyn Products, Mellingmedical, Mevion, Ms Wil, Mylabbox, Microport CRM, Neoline Technology, Newomics, Nuvision, Ossur, Proton International, Pulmonary Fibrosis Foundation, Relay Medical, Rhino Novi, Senseonics, Sg Blocks, Sonifi, Stella Diagnostics, Theator, Thomas Medical, Wise Analysis Instruments.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Neurometrix, Sherlock Biosciences.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arch, Astrazeneca, Athenex, BMS, GSK, Inmune, Mirum, Nkmax, Novo, Plus, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aegis, Altimmune, Altum, Antios, Applied Biomath, Aptorum, Astellas, Astrazeneca, Bavarian Nordic, Betterlife, Boston Pharmaceuticals, Daré, Dcprime, Domain, Elix, Elixirgen, Emergex, Entos, Flame, Glaxosmithkline, HDT Bio, Humanigen, Immpronano, Immunobrain, Medicinova, Mirum, Neuclone, Northwest Biotherapeutics, Novartis, Oxford Biomedica, PCI, Pfizer, Recce, Relation Therapeutics, Revision, Rodeo, Sonnet, Tavanta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alimera, Annovis, Aptevo, Arena, Astrazeneca, Biophytis, BMS, Cartesian, Clear Creek, Genfit, Hepion, Immunomic, Innovent, Iveric, Kuros, Orchard, Oxurion, Sanofi, Transcenta.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Arrakis, Bharat, Biocryst, Cheplapharm, Elektrofi, Glycomimetics, Immutep, Kalos, Leo, Ligand, Lineage, Maat, Metagenomi, Mindset, Novavax, PDL, Qualigen, Resverlogix, Regulus, Sanofi, Seneca, Sotio, Unum, Vallaurix, Vor.